These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36252315)

  • 1. Microfluidic chip with reversible interface for noninvasive remission status monitoring and prognosis prediction of acute myeloid leukemia.
    Lai Q; Song J; Zha J; Zheng H; Deng M; Liu Y; Lin W; Zhu Z; Zhang H; Xu B; Yang C
    Biosens Bioelectron; 2023 Jan; 219():114803. PubMed ID: 36252315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
    Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P
    Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
    de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
    Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of CD34
    Zahran AM; Aly SS; Rayan A; El-Badawy O; Fattah MA; Ali AM; ElBadre HM; Hetta HF
    Oncotarget; 2018 Sep; 9(75):34056-34065. PubMed ID: 30344921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F; Al-Mudallal SS
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia.
    Kandeel EZ; El Sharkawy N; Hanafi M; Samra M; Kamel A
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):383-393. PubMed ID: 32201129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia.
    Kamel AM; Elsharkawy NM; Kandeel EZ; Hanafi M; Samra M; Osman RA
    Front Oncol; 2022; 12():867684. PubMed ID: 35530356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of Leukemia Stem Cells in Acute Myeloid Leukemia before and after Treatment].
    Lv JT; Yang ZG; Guang YH; Lin ZS; Xiao XX; Liu D; Shi M; Wang WS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):658-664. PubMed ID: 29950200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic Stem Cell (CD34
    Mohamed MMI; Aref S; Agdar MA; Mabed M; El-Sokkary AMA
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):508-513. PubMed ID: 33931379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of WT1 gene in CD34(+)CD38(-)CD123(+) AML stem cells and its significance analysis.].
    Xu J; Wang HW; Yang T; Tan YH; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):172-5. PubMed ID: 20510107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.
    Jaddaoui S; Bencharef H; Lamchahab M; Quessar A; Oukkache B
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster of differentiation 96 as a leukemia stem cell-specific marker and a factor for prognosis evaluation in leukemia.
    DU W; Hu Y; Lu C; Li J; Liu W; He Y; Wang P; Cheng C; Hu YU; Huang S; Yao J; Zheng J
    Mol Clin Oncol; 2015 Jul; 3(4):833-838. PubMed ID: 26171191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
    Zhi L; Wang M; Rao Q; Yu F; Mi Y; Wang J
    Cancer Lett; 2010 Oct; 296(1):65-73. PubMed ID: 20444543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy.
    Kikushige Y
    Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
    Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
    Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.
    Han L; Jorgensen JL; Brooks C; Shi C; Zhang Q; Nogueras González GM; Cavazos A; Pan R; Mu H; Wang SA; Zhou J; Ai-Atrash G; Ciurea SO; Rettig M; DiPersio JF; Cortes J; Huang X; Kantarjian HM; Andreeff M; Ravandi F; Konopleva M
    Clin Cancer Res; 2017 Jul; 23(13):3385-3395. PubMed ID: 28096272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.